1. Home
  2. PRLB vs MLTX Comparison

PRLB vs MLTX Comparison

Compare PRLB & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$53.65

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.87

Market Cap

979.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLB
MLTX
Founded
1999
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
979.8M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
PRLB
MLTX
Price
$53.65
$15.87
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$53.00
$22.22
AVG Volume (30 Days)
124.7K
3.5M
Earning Date
02-06-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$518,384,000.00
N/A
Revenue This Year
$7.07
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$90.17
N/A
Revenue Growth
2.82
N/A
52 Week Low
$29.59
$5.95
52 Week High
$56.60
$62.75

Technical Indicators

Market Signals
Indicator
PRLB
MLTX
Relative Strength Index (RSI) 51.19 54.01
Support Level $52.95 $15.70
Resistance Level $56.60 $16.86
Average True Range (ATR) 1.64 1.29
MACD -0.03 0.09
Stochastic Oscillator 51.68 62.14

Price Performance

Historical Comparison
PRLB
MLTX

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: